This collection of articles from The Scientist explores some of the latest cancer research!

Joseph Powell will discuss how heterogeneous subpopulations of HPV+ head and neck cancer cells drive unique disease states, cell-cell interactions, and microenvironment dynamics, and have implications for cancer behavior, metastasis, and response to treatment.   

Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.

Pier Paolo Pandolfi left Harvard University last year following allegations of sexual harassment, and has since been accused of research misconduct.

A cancer researcher with a talent for leadership, Marks turned the Memorial Sloan Kettering Cancer Center into one of the world’s foremost oncology research institutions.

A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.

The Creighton University researcher discovered the genetic basis of hereditary breast-ovarian cancer syndrome.

The Centers of Cancer Nanotechnology Excellence were established in 2005 through several phases of funding, which are reported to end next year.

The former head of cancer medicine at MD Anderson Cancer Center helped change clinical practice for laryngeal cancer and helped establish chemoprevention.

Nine of the most recent retractions from AACR journals are for papers coauthored by embattled cancer researcher Bharat Aggarwal.

Men received both more and larger grants than women did, ending up with three times as much funding on average.

3-D balls of cells can be used to screen for potential cancer drugs.

Treating mice with anti-inflammatory drugs following surgery reduced the size of tumors.

Macrophages play numerous roles within tumors, leaving cancer researchers with a choice: eliminate the cells or recruit them.

Most of the authors have had papers pulled in the past.

Scientists shut down cancer-causing fusion genes with CRISPR.

Ben Henry explores the science behind a deep-fried cancer scare and traditional treatments that may shrink tumors.

Notable quotes from this year’s annual meeting of the American Association for Cancer Research

At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.